ANTI CANCER MEDICATION
40 mg Resihance Regorafenib Tablets
Price on Request
Resihance 40 mg (Regorafenib) is a targeted tyrosine kinase inhibitor used to treat metastatic colorectal cancer, advanced gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma. Manufactured by Bayer, the tablets work by slowing tumor growth and blocking the blood supply that cancer cells need.
Composition
Strength 40 mg
Dosage Form 40 mg
Composition Regorafenib Film Coated Tablets
Pack Size 28 Tablets
Form Tablet
Manufacturer Bayer
Brand Reshihance
Usage GIST
Packaging Size 28 Tablets
Packaging Type Box
Minimum order quantity: 50 Box
Enquire About This Product